Last edition
News about "Genomic Profiling"
Tempus Wins FDA Approval for xT CDx, Expanding Solid Tumor Testing Portfolio
Tempus has received US FDA approval for its tumor-only xT CDx, becoming the first laboratory with companion diagnostic approval for both tumor-only and tumor-normal genomic profiling.
Genomic Profiling | 30/05/2026 | By News Bureau
Biofidelity and CellCarta Announce Partnership to Enhance NSCLC Clinical Trials with Aspyre Lung
Aspyre Lung simplifies the detection of established non-small cell lung cancer (NSCLC) biomarkers by analysing both DNA and RNA from tissue and blood using a streamlined four-step workflow.
Genomic Profiling | 17/01/2025 | By Abha | 331
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy